Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis

NCT ID: NCT04989114

Last Updated: 2021-08-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

96 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-09-06

Study Completion Date

2021-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to assess the effectiveness of nasal continuous positive airway pressure in reducing respiratory distress in children with bronchiolitis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study, after taking consent from caretakers, patients of brochiolitis will be randomly assigned to either a standard care group or a nasal continuous positive airway pressure group. Both groups will be followed for respiratory distress. Respiratory distress will be compared by using Seattle sore of respiratory distress.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchiolitis Acute Viral Bronchiolitis Bronchiolitis Acute Bronchiolitis, Viral Nasal Continuous Positive Airway Pressure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard care

In this arm, oxygen inhalation will be provided without positive end expiratory pressure

Group Type NO_INTERVENTION

No interventions assigned to this group

nasal continuous positive airway pressure

In this arm, positive end expiratory pressure will be provided by nasal continuous positive airway pressure

Group Type EXPERIMENTAL

nasal continuous positive airway pressure

Intervention Type DEVICE

positive end expiratory pressure will be applied by nasal continuous positive airway pressure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nasal continuous positive airway pressure

positive end expiratory pressure will be applied by nasal continuous positive airway pressure

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children presenting with history of cough, and tachypnea and wheezing on clinical examination

Exclusion Criteria

* Patients needing mechanical ventilation at the time of admission
* Patients whose caretakers refuse written informed consent
* Patients having consolidation on chest X-Ray
Minimum Eligible Age

2 Months

Maximum Eligible Age

2 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

King Edward Medical University

OTHER

Sponsor Role collaborator

ameer asadullah gull

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ameer asadullah gull

Postgraduate Resident Pediatric Medicine

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Muhammad Haroon Hamid, MBBSFCPSFRCS

Role: PRINCIPAL_INVESTIGATOR

King Edward Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Hospital

Lahore, Punjab Province, Pakistan

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ameer Asadullah Gull, MBBS

Role: CONTACT

00923084860184

Muhammad Haroon Hamid, MBBSFCPSFRCS

Role: CONTACT

00923008880916

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ameer Asadullah Gull, MBBS

Role: primary

00923084860184

Muhammad Haroon Hamid, MBBSFCPSFRCS

Role: backup

00923008880919

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

704/RC/KEMU

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.